GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 420 filers reported holding GUARDANT HEALTH INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62 | -20.5% | 2,107 | -2.9% | 0.00% | – |
| Q2 2023 | $78 | -51.9% | 2,170 | -68.6% | 0.00% | -100.0% |
| Q1 2023 | $162 | -16.5% | 6,900 | -3.1% | 0.00% | 0.0% |
| Q4 2022 | $194 | -99.9% | 7,123 | +10.2% | 0.00% | -50.0% |
| Q3 2022 | $348,000 | +30.3% | 6,466 | -2.3% | 0.00% | +100.0% |
| Q2 2022 | $267,000 | -41.6% | 6,620 | -4.1% | 0.00% | -50.0% |
| Q1 2022 | $457,000 | -31.5% | 6,900 | +3.4% | 0.00% | 0.0% |
| Q4 2021 | $667,000 | -14.7% | 6,673 | +6.6% | 0.00% | -33.3% |
| Q3 2021 | $782,000 | +12.4% | 6,257 | +11.6% | 0.00% | 0.0% |
| Q2 2021 | $696,000 | -6.5% | 5,607 | +15.0% | 0.00% | 0.0% |
| Q1 2021 | $744,000 | +70.6% | 4,875 | +44.1% | 0.00% | +50.0% |
| Q4 2020 | $436,000 | +46.3% | 3,383 | +26.8% | 0.00% | +100.0% |
| Q3 2020 | $298,000 | +1555.6% | 2,667 | +1112.3% | 0.00% | – |
| Q2 2020 | $18,000 | – | 220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |